Harper James is a UK full-service commercial law firm advising businesses on the laws of England and Wales, including fundraising and corporate matters. Due diligence in a funding round is the process by which prospective investors examine a company before committing capital. It tests the accuracy of information presented to investors and identifies legal, financial, commercial and operational issues that affect the investment.
The review commonly covers the company’s incorporation records, articles of association, shareholder agreements, cap table and previous funding documents. Investors also examine material customer and supplier contracts, intellectual property ownership, employment arrangements, data protection compliance, borrowing, litigation, regulatory obligations and any commitments to issue further shares or options. The scope depends on the size, stage and structure of the round.
A company normally prepares a secure data room containing relevant documents, indexed against an investor due diligence request list. The company should reconcile its cap table with Companies House records and historic investment documents, confirm that founders and employees have assigned intellectual property, and identify contracts requiring consent to a change in ownership or control.
Early review of these materials allows inaccuracies and missing documents to be addressed before they delay the transaction. Issues are usually recorded in a disclosure schedule or disclosure letter. Depending on their seriousness, they may lead to amended investment terms, specific warranties, an indemnity, a condition to completion or a decision by the investor not to proceed.
The due diligence findings inform the investment agreement, shareholders’ agreement and amended articles of association. These documents set out the number and class of shares issued, the subscription price, investor rights, governance arrangements, information rights, restrictions on transfers and provisions for future funding or an exit. The company’s existing shareholders may also need to waive pre-emption rights or approve the issue of new shares.
The process does not remove every business risk. Its function is to give investors a basis for deciding whether to invest and on what terms, while giving the company an opportunity to correct records and allocate known risks contractually. A well-organised review links the evidence in the data room to the warranties, disclosures and completion requirements in the funding documents.